Total Hip Replacement (THR) is widely assumed to resolve sleep disturbance commonly experienced by individuals with hip osteoarthritis (OA). We report a study of 329 THRs with mean age of 71.9 years comparing pre-operative and one and two year post-operative patient reported outcomes for sleep disturbance to determine the veracity of this expectation. Data was collected from the validated Oxford Hip Patient Reported Questionnaire. Specifically, Question 12: “During the past four weeks, have you been troubled by pain from your hip in bed at night?” Answers to the question were multiple choice: No nights (4 points), Only 1 or 2 nights (3 points), Some nights (2 points), Most nights (1 point) and Every Night (0 points) Pre-operatively, the mean score for patients with hip OA was 1.2/4. This increased to 3.5 at one year and was also maintained at two years. The pre- to post-operative improvement was significant at both one and two years for THR with p <0.00001. Pre-operatively, only 6% of patients with arthritic hips reported that they were never woken from sleep because of their painful hip. One year after THR 72% always enjoyed pain free sleeping and at two years this had risen to 75%. When patients who only experienced disturbance one or two nights per month were included, the three figures increased from 13% to 83% and 83% respectively. The study confirms that sleep disturbance affects over 90% of patients with arthritic hip joints. Over 80% of THR patients will enjoy sleep that is seldom or never disturbed by their artificial hip. The improvement achieved by THR occurs within a year of surgery and is preserved at two years. In this regard, hip replacement is a highly effective intervention.
Bone stock loss secondary to debris and mechanic alin-stability presents a challenge in revision hip arthroplasty. The aim of our study is to evaluate the clinical outcome of revision hip arthroplasty using the Oxford hip prosthesis combined with impaction allografting. Between 1999 and 2002, we revised 72 hips in 69 patients using this technique (mean age 65years). Indications were aseptic loosening (56), infection (8), peri-prosthetic fracture (7) and a broken stem (1). The mean time to revision was 8.5 years (1–21years). Patients were assessed clinically and with the Oxford Hip Score (OHS) pre- and post-operatively. Fifty-seven patients also had acetabular revision. Four patients required femoral osteotomy to remove the old prosthesis. We used a mean of 1.8 (1–4) femoral heads per operation. Patients were mobilised partially weight bearing (8weeks) followed by a gradual return to full loading. Complications included peri-operative femoral fracture (6), infection (6), dislocation (10), DVT (1)and PE (2). The average blood transfusion was 1.8 units (0–9). The OHS improved from 45 (26–58) pre-operatively to 24.3 post-operatively (12–43). No hip has been re-revised for aseptic loosening at a mean follow-up of 32.7months (16–51). The Oxford hip is a trimodular prosthesis with a polished tapered metaphyseal section that is free to slide and rotate on the stem. The stem is first inserted uncemented into the diaphysis. Bone graft is impacted proximally, with mesh if necessary, and then the proximal wedge is cemented in. The wedge allows for some subsidence in the cement and creates optimal radial force transmission, which is essential for bone-remodelling stimulation and preventing proximal stress shielding. Although this is a short-term experience, we believe that the use of the tri-modular Oxford stem combined with minimal proximal impaction allografting is a reliable method of dealing with difficult revision femoral surgery. The results were comparable with a primary arthroplasty in terms of pain relief and functional results.
Between 1999 and 2002, we revised 72 hips in 69 patients using this technique (mean age 65years, 28 to 88). Fifty-six cases had aseptic loosening, 8 had infection (2 stages), 7 had peri-prosthetic fractures and 1 had a broken stem. The mean time to revision was 8.5years (1 to 21). Patients were assessed clinically and with the Oxford Hip Score (OHS) pre- and post-operatively. Fifty-seven patients also had acetabular revision. Four patients required femoral osteotomy to remove the old prosthesis. We used a mean of 1.8 (1 to 4) femoral heads per operation. Complications included 6 peri-operative femoral fractures diagnosed at operation and fixed successfully, 6 infections, 10 dislocations (2 were recurrent), one deep vein thrombosis, 2 pulmonary embolism and one gastrointestinal haemorrhage. The average blood transfusion was 1.8 units (0 to 9). The OHS improved from 45 (26 to 58) pre-operatively to 24.3 post-operatively (12 to 43). No hip has been re-revised for aseptic loosening at a mean follow-up of 32.7 months (16 to 51).
The aim of the study was to measure in-vivo the 10-year linear and volumetric polyethylene wear of a fully congruent mobile bearing unicompartmental knee arthroplasty (OUKA). We studied six OUKA’s that had all been implanted 10 years previously. Each patient was examined in even double leg stance at a range of knee flexion angles, in a calibration cage. A stereo pair of X-ray films was acquired for each patient at 0°, 15° and 30° of flexion. The films were analysed using an RSA style calibration and a CAD model silhouette-fitting technique. The position and orientation of each femoral and tibial component was found relative to each other and the bearing position inferred. Penetration of the femoral component into the original volume of the bearing was our estimate of linear wear. The volumetric wear is calculated from the measured linear wear and the known surface area of the bearing. In addition eight control patients were examined less than 3 weeks post-operation where no wear would be expected.and 30We studied seven OUKA’s that had all been implanted at least 10 years previously. A stereo pair of X-ray films was acquired for each patient at 0 Results: The control group showed no measured wear. The seven OUKA’s had an average maximum depth of linear penetration of 0.40 mm at a mean follow-up of 10.9 years. The linear wear rate was 0.033 mm/year. The volumetric material loss was 79.8 mm3. If a steady gradual material loss is assumed, 8 mm3 of UHMWPE was lost per year. Polyethylene particulate wear debris continues to be implicated in the aetiology of component loosening and implant failure knee following arthroplasty. The OUKA employs a spherical femoral component and a fully congruous meniscal bearing to increase contact area and theoretically reduce the potential for polyethylene wear. The results from this in-vivo study confirm that the device has low 10-year linear and volumetric wear in clinical practice. This may protect the device from component loosening in the long term.
Polyethylene wear can be an important cause of knee replacement failure. Six TKRs in young, active patients with excellent Oxford Knee Scores and Knee Society Scores, mean 76 months post knee replacement and 5 control patients, 2 weeks post TKR, were selected. Each patient had weight bearing stereo radiographs of at 0, 15, 30, 45 and 60 degrees of flexion while standing in a calibration grid. These x-rays were analysed using our Radio Stereometric Analysis (RSA) system. The three-dimensional shape of the TKR (manufacturer’s computer aided design model) was matched to the TKR silhouette on the calibrated stereo radiographs for each angle of flexion. The relative positions of the femoral and tibial components in space were then determined and the linear and volumetric penetration was calculated using Matlab software. The accuracy of the system was found to be 0.3mm (CAD model tolerance 0.25mm). The mean linear wear in the control patients was 0.02mm (range −0.19 to +0.23mm). Average linear penetration in the study group was found to be 0.6 mm at 6 years, giving an overall linear wear rate of 0.1mm/year. Average penetration volume at 76 months was 399mm3. The average volumetric wear rate was 63mm3/year. It is possible to measure volumetric wear in vivo using RSA. Volumetric wear rate was found to be 63mm3 per year. Studies on retrieved normally functioning hip replacements have shown volumetric wear rates of 35mm3 per year. However, clinical outcomes of knee replacements are comparable to those of hip replacements, suggesting that the knee has a more effective mechanism for dealing with polyethylene wear particles.